Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 January 2021 | Story Leonie Bolleurs | Photo Supplied
Hay’s family celebrated his graduation ceremony with him in 2013. Pictured here are Frank Hay (father), Hay, his brother, Shanley and his mother, Vasi Hay.

Diversity, inclusivity, and transformation are what sets the University of the Free State (UFS) apart from other institutions of tertiary education. It instils in graduates the values of attention to detail and precision, being meticulous, adherence to deadlines, being honest, ethical, and taking the ‘moral high ground’. 

Graduates at the UFS are also introduced to high levels of dedication and commitment, irrespective of the task at hand; taking pride in producing work of high quality; having a non-discriminatory mindset; the ability to be team players or leaders (depending on what needs to be done); and demonstrating an understanding and consideration for society at large. 

This is the view of Ashley Hay, a successful UFS alumnus who completed his honours (accepted through the Recognition of Prior Learning process) and master’s degrees (graduating cum laude) in the Department of Urban and Regional Planning. Throughout his academic career, Hay has achieved good results and accolades such as Best Master’s Student, Best Master’s Dissertation, Best Research in Advanced Planning Practice, and also receiving membership of the Golden Key International Honour Society.

Today, he is employed by the Gauteng Provincial Government as Director: Land Use Management and Statutory Boards in the Office of the Premier and is in transition to a new branch called ‘Urban Planning’ under the Minister for Cooperative Governance, Urban Planning and Human Settlements.  

He leads a team of professionals on spatial planning and land use management aspects, and particularly to monitor and support three metropolitan municipalities, two district municipalities, and six local municipalities in Gauteng. His achievements include the development of a policy document titled, Gauteng City Region Implementation Plan for SPLUMA, which was approved by the Provincial Cabinet Executive Council and endorsed by the Premier’s Coordinating Forum. At a previous place of employment, the uMshwathi Local Municipality, he was the author of one of the best Integrated Development Plans (IDPs), which received an award in KwaZulu-Natal.

Proudly UFS

Hay believes he was equipped with a set of values and skills to deliver services and to make a difference wherever he is. Not only through the resources and means available to him, but also with a high level of dedication to the general good of others – whether it is ordinary citizens or people who just need the very basics to uplift their livelihoods. “These basics should be forthcoming from the people’s government, which in turn implicates me among many other government employees,” he believes.

Hay says in the UFS Department of Urban and Regional Planning – from the administration team through to the lecturers and senior academics – everyone plays a role to instil a wealth of knowledge and expertise in students to understand and resolve societal problems. “It is the manner in which the course is conducted, the administrative facilitation, the steadfast pace of learning, as well as the personal attention to students, that have equipped us to later formulate solutions for everyday life challenges.”

He is convinced that these are the fundamental principles that graduates need to achieve academic excellence and make themselves employable in a competitive world.

Words that stick with Hay from his master’s classes, are those of the former Head of the Department, Prof Das Steyn, “Gain experience, build your capacity, and do something positive with the education you receive. Education is not what we teach you, it is what you do with it. Everyone gets the same degree, but some will fail with it and some will do something positive with it and make a difference”. 

Standing out

And UFS graduates distinguish themselves in the workplace.

“In my work environment, the UFS graduates I know and have worked with are dedicated, goal-orientated, and passionate about the discipline. We go the ‘extra mile’ irrespective and have been able to apply the knowledge we gained from university towards problem-solving and contributing to make society a better place for all,” says Hay.

He also believes that the university has strong leadership and dedicated staff who actively respects the country’s rich diversity, acknowledging that we are an all-inclusive society, and creating a learning atmosphere that is transformed towards democratic principles.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept